Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccines.
about
Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimenIn vitro evaluation of TLR4 agonist activity: formulation effects.Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate.Adeno-associated virus-like particles as new carriers for B-cell vaccines: testing immunogenicity and safety in BALB/c miceMeasuring naturally acquired ex vivo IFN-γ responses to Plasmodium falciparum cell-traversal protein for ookinetes and sporozoites (CelTOS) in Ghanaian adults.Recent advances in recombinant protein-based malaria vaccines.Particle-based platforms for malaria vaccines.Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate.Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis.Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activitySafety, immunogenicity, and cross-species protection of a plasmid DNA encoding Plasmodium falciparum SERA5 polypeptide, microbial epitopes and chemokine genes in mice and olive baboons.An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models.IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants.CpG-mediated augmentation of CD8+ T-cell responses in mice is attenuated by a water-in-oil emulsion (Montanide ISA-51) but enhanced by an oil-in-water emulsion (IDRI SE).Protein nanovaccine confers robust immunity against Toxoplasma.A real-time impedance-sensing chip for the detection of emulsion phase separation.Charged Aerosol Detection
P2860
Q21089693-0EA30D24-4C62-45BF-84B1-C77BB8687506Q30561113-3492DA32-CFAA-4A35-8EF2-CF2D4F65D27DQ33743450-37D99137-4238-45AD-94B4-C6D901FAB8D3Q34232909-08222660-E4D4-4D9B-B1CD-A4258632BAF8Q34440125-3799AEB5-9DD8-4911-9BA9-0E4A4300F2C8Q35021277-6C648304-C594-4BF8-8AA4-A181D4EB06E2Q36394182-1FA695D8-79B5-4B4C-9DFF-0622CAB797BEQ36396040-DA62FE19-AD51-418B-9107-A6A2CC6D8753Q36555077-B220EE2E-2F81-409B-B984-8FC208EB4546Q37410524-59439C03-D64A-4B95-A83C-DB648040C963Q37434381-F8399ED9-C765-44A4-AAA9-F400F427259AQ38849255-63A34B41-1110-49BE-9E63-82204C83962CQ40095257-E485235A-B079-44F3-A08C-3679A712C177Q40476014-A2EC94EA-F0A3-479B-A9EE-44A08FA3B18EQ40724264-4F2925C1-C9AD-4D23-BDD6-E17941B8CE1BQ47102683-11D6BD6F-0558-4B70-8FD9-0345DFA430C3Q51530742-2966BE25-B918-482B-84E3-21905C926FDEQ57340538-AE7F1D4F-91EB-466E-865D-236069E708E1
P2860
Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccines.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Effects on immunogenicity by f ...... djuvants for malaria vaccines.
@ast
Effects on immunogenicity by f ...... djuvants for malaria vaccines.
@en
type
label
Effects on immunogenicity by f ...... djuvants for malaria vaccines.
@ast
Effects on immunogenicity by f ...... djuvants for malaria vaccines.
@en
prefLabel
Effects on immunogenicity by f ...... djuvants for malaria vaccines.
@ast
Effects on immunogenicity by f ...... djuvants for malaria vaccines.
@en
P2093
P2860
P356
P1476
Effects on immunogenicity by f ...... djuvants for malaria vaccines.
@en
P2093
Evelina Angov
Susan L Baldwin
Thomas S Vedvick
P2860
P304
P356
10.1128/CVI.00235-12
P577
2012-08-15T00:00:00Z